Tevogen Inc. Common Stock
TVGN
54 hedge funds and large institutions have $3.78M invested in Tevogen Inc. Common Stock in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 5 closing their positions.
0% less ownership
Funds ownership: 0.05% → 0.05% (-0%)
4% less funds holding
Funds holding: 56 → 54 (-2)
18% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 22
37% less capital invested
Capital invested by funds: $6.04M → $3.78M (-$2.26M)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$80.7K |
| 2 |
Goldman Sachs
New York
|
+$40.3K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$32.5K |
| 4 |
VF
Virtu Financial
New York
|
+$14.2K |
| 5 |
Bank of New York Mellon
New York
|
+$9.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$43K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$39.5K |
| 3 |
State Street
Boston,
Massachusetts
|
-$28.2K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$27.1K |
| 5 |
SG Americas Securities
New York
|
-$26K |
TVGN Hedge Fund Activity: Q3 2025 in Review
54 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Tevogen Inc. Common Stock (TVGN) for Q3 2025, worth a combined $3.78M — down 37% from $6.04M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of TVGN and 3 opened new positions — a net loss of 2 holders — while 22 trimmed existing stakes and 18 added.
The largest buyer was BlackRock, adding an estimated $80.7K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $43K sold.
- 54 institutional investors held Tevogen Inc. Common Stock (TVGN) as of Q3 2025, down from 56 in Q2 2025.
- Funds reported $3.78M of Tevogen Inc. Common Stock stock for Q3 2025, down 37% quarter-over-quarter.
- 3 funds opened new Tevogen Inc. Common Stock positions in Q3 2025 and 5 closed out, a net change of -2 holders.
- The largest Tevogen Inc. Common Stock buyer in Q3 2025 was BlackRock, an estimated $80.7K added.
- The largest Tevogen Inc. Common Stock seller in Q3 2025 was Susquehanna International Group, an estimated $43K sold.
Based on aggregated 13F filings for Q3 2025.